This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The University of Texas System, Other. Active years: 2013-2020.
Company Filing History:

Years Active: 2013-2020
Title: Innovations and Contributions of Inventor Lawrence Lum
Introduction
Lawrence Lum is a notable inventor based in Dallas, TX (US), recognized for his significant contributions to the field of pharmaceuticals and biotechnology. He holds a total of 6 patents, showcasing his innovative approach to solving complex medical challenges.
Latest Patents
One of his latest patents is titled "Disubstituted and trisubstituted 1,2,3-triazoles as Wnt inhibitors." This patent provides compounds that may be useful for inhibiting the Wnt pathway, which is crucial in various biological processes. The compounds described can potentially be used to treat conditions such as cancer, myocardial infarction, and osteopetrosis, as well as aid in the maturation of precursor cells. Additionally, pharmaceutical compositions of these compounds are also included in the patent.
Another significant patent by Lawrence Lum is "Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof." This patent focuses on compounds that inhibit the Tankyrase enzyme, which is linked to several diseases, including cancer and degenerative disorders. The compounds may also prevent the elongation of telomeres in cells, offering a promising avenue for therapeutic interventions.
Career Highlights
Lawrence Lum has worked with the University of Texas System, contributing to various research initiatives and projects. His work has had a profound impact on the development of new treatments and therapies in the medical field.
Collaborations
Throughout his career, Lawrence has collaborated with notable individuals such as Chuo Chen and Michael G Roth. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Lawrence Lum's contributions to the field of invention and innovation are significant, particularly in the realm of pharmaceuticals. His patents reflect a commitment to advancing medical science and improving patient outcomes.